Evaluating Cell Viability After Cryopreservation
Hawkins, B. J., Abazari, A., Mathew, Aby. J. Evaluating Cell Viability After Cryopreservation. PDA Letter. July 2018.
Read MoreTag: CryoStor
Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse
Barrachina, L., Romero, A., Zaragoza, P., Rodellar, C., Vázquez, F. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse. The Veterinary Journal. 2018; 238, 49-57. doi:10.1016/j.tvjl.2018.07.004
Read MorePractical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse
Barrachina, L., Romero, A., Zaragoza, P., Rodellar, C., Vázquez, F. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse. The Veterinary Journal. 2018; 238, 49-57. doi:10.1016/j.tvjl.2018.07.004
Read MoreHigh dimensional analyses of cells dissociated from cryopreserved synovial tissue
Donlin, L. T., Rao, D. A., Wei, K., Slowikowski, K., McGeachy, M. J., Turner, J. D., Meednu, N., Mizoguchi, F., Gutierrez-Arcelus, M., Lieb, D. J., Keegan, J., Muskat, K., Hillman, J., Rozo, C., Ricker, E., Eisenhaure, T. M., Li, S., Browne, E. P., Chicoine, A., Sutherby, D., Noma, A., Nusbaum, C., Kelly, S., Pernis, A.…
Read MoreBiomanufacturing for clinically advanced cell therapies
Aijaz, A., Li, M., Smith, D., Khong, D., LeBlon, C., Fenton, O. S., Olabisi, R. M., Libutti, S., Tischfield, J., Maus, M. V., Deans, R., Barcia, R. N., Anderson, D. G., Ritz, J., Preti, R., Parekkadan, B. Biomanufacturing for clinically advanced cell therapies. Nature Biomedical Engineering 2018; 2(6), 362-376. doi:10.1038/s41551-018-0246-6
Read MoreCD73, CD90, CD105 and Cadherin-11 RT-PCR Screening for Mesenchymal Stem Cells from Cryopreserved Human Cord Tissue
Pham, H., Tonai, R., Wu, M., Birtolo, C., Chen, M. CD73, CD90, CD105 and Cadherin-11 RT-PCR Screening for Mesenchymal Stem Cells from Cryopreserved Human Cord Tissue. Int. J. Stem Cells 2018; 11(1): 26-38. doi:10.15283/ijsc17015
Read MoreCD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy
HemaCare. CD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy. May 2018: 1-4
Read MoreTranscription Factor-Mediated Differentiation of Human iPSCs into Neurons.
Fernandopulle, M., Prestil, R., Grunseich, C., Wang, C., Gan, L., Ward, M. Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons. Current Protocols In Cell Biology 2018; 79(1), e51. doi:10.1002/cpcb.51
Read MoreSV-BR-1-GM, A Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses An Immune Signature And Directly Activates CD4+ T Lymphocytes
Lacher, M. D., Bauer, G., Fury, B., Graeve, S., Fledderman, E. L., Petrie, T. D., Coleal-Bergum, D. P., Hackett, T., Perotti, N. H., Kong, Y. Y., Kwok, W. W., Wagner, J. P., Wiseman, C. L., Williams, W. V. SV-BR-1-GM, A Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses An Immune Signature And Directly Activates CD4+…
Read MoreThe Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality
Lou Juliano, George Eastwood, Todd Berard, Aby J. Mathew. The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality. Cell Gene Therapy Insights 2018; 4(4), 327-336. doi: 10.18609/cgti.2018.032
Read More